Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection

Table 2 Factors potentially influencing Helicobacter pylori eradication, n (%)

Factor	Eradication failure (n = 5)	Successful eradication (n = 63)	P value
Sex (male)	2 (40.0)	18 (28.6)	0.627
Age (yr), mean ± SD	54.40 ± 5.86	49.22 ± 10.80	0.295
Height (m), mean ± SD	1.62 ± 0.10	1.62 ± 0.07	0.778
Weight (kg), mean ± SD	64.60 ±11.42	59.12 ± 12.37	0.129
BMI (kg/m2), mean ± SD	24.43 ± 1.88	22.14 ± 3.70	0.112
Concomitant disease
Diabetes mellitus	1 (20.0)	8 (12.7)	0.520
Hypertension	1 (20.0)	13 (20.6)	1.000
Anxiety disorder	2 (40.0)	2 (3.2)	0.025
Gastroscopy findings
Atrophic gastritis	2 (40.0)	31 (49.2)	1.000
Non-atrophic gastritis	3 (60.0)	21 (33.3)	0.337
Peptic ulcer	0 (0.0)	4 (6.3)	1.000
Polyp	0 (0.0)	1 (1.6)	1.000
No. of prior treatments
1	3 (60.0)	44 (69.8)	0.641
≥ 2	2 (40.0)	19 (30.2)

BMI: body mass index.